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osting by EAbstract Toxicity and effects of an antiepileptic drug, carbamazepine (CBZ) on transaminases like
glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT); lactate
dehydrogenase (LDH) activities in gill, liver and muscle of a freshwater ﬁsh, Cyprinus carpio were
investigated. The median lethal concentration (LC50) of CBZ to C. carpio for 24 h was determined
(59.70 mg ll). 1/10th of LC50 value was taken as a sublethal concentration (5.97 mg l
l). Fish were
exposed to both acute and sublethal CBZ concentration for 24 h and 35 days (at weekly intervals),
respectively. During acute treatment, GOT activity was decreased in all the organs (gill, liver and
muscle); GPT and LDH activities were increased in liver and muscle while decreased in gill. During
sublethal treatment, GOT activity was decreased in liver and muscle, whereas GPT activity was
increased in these two organs. A biphasic trend was noted in GOT and GPT activity in gill and
LDH activity in gill, liver and muscle. The present study indicates that CBZ induced alterations
in the activities of GOT, GPT and LDH in various organs of ﬁsh; these enzymes may be used as
logical candidates to monitor the toxic levels of pharmaceuticals in aquatic organisms.
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lsevier1. Introduction
The presence of pharmaceuticals and personal care products
(PPCPs) in the aquatic ecosystem has emerged as a serious
concern due to their rapid growing and unregulated disposal
practices (Richardson and Bowron, 1985; Daughton and
Ternes, 1999; Zuccato et al., 2005; Laura Martı´n-Dı´az et al.,
2009). These aquatic micropollutants disturb the ecological
balance and attracted the public as well as scientiﬁc commu-
nity (Halling-Sørensen et al., 1998; Yamamoto et al., 2009).
As a result, a number of investigations have been reported
on widespread occurrence of pharmaceuticals in the aquatic
environment (Ternes, 1998; Gomez et al., 2007; Letzel et al.,
2009).
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(anti-inﬂammatory, beta-blockers, sympathomimetics, antiepi-
leptics, lipid regulators, antibiotics, etc.) have been reported in
sewage, rivers and creeks, seawater, surface water, groundwa-
ter and drinking water resources throughout the world (Fent
et al., 2006; Choi et al., 2008; Rosal et al., 2009). Major cause
of the population crash in vultures due to diclofenac provided
evidence in India and Indian subcontinent, Pakistan and Nepal
(Oaks et al., 2004; Shultz et al., 2004; Muralidharan and
Dhananjayan, 2010). Although these emerging pollutants
introduced into aquatic environment by discharges from sew-
age treatment plants, industrial and hospital wastewater, land-
ﬁll leachates, disposal of unused drugs, efﬂuents from
aquaculture, agricultural use and so on (Daughton and
Jones-Lepp, 2001; Thomas and Hilton, 2004; Isidori et al.,
2005; Kasprzyk-Hordern et al., 2009), the occurrence of drugs
in the environment was usually in low concentrations (ng-
Ag/L), where in rivers, lakes and seawater ranges from ng/L
(Zuccato et al., 2000; Thomas and Hilton, 2004; Gros et al.,
2006). Many pharmaceuticals are not completely degraded
after application, upon entering to the aquatic ecosystem the
metabolites and some unchanged form may interfere with
molecules, cells and organs of aquatic organisms due to their
lipophilic nature and may leads to biological effect (Halling-
Sørensen et al., 1998; Fent et al., 2006). In aquatic environ-
ment, the impact of drugs on organisms may occur after a long
term exposure of pharmaceuticals at lower concentrations; and
this to the non-target organisms is scanty (Thibaut and Porte,
2008).
In the present study we aimed to investigate the toxicity and
impact of carbamazepine on certain enzymatic parameters of a
freshwater ﬁsh Cyprinus carpio to ﬁll up this lacuna. The selec-
tion of this group is based on the fact among different groups
of pharmaceuticals detected in the aquatic environment. CBZ
is a frequently detected pharmaceutical residue and anthropo-
genic marker in water bodies (Clara et al., 2004). CBZ is
consistently found in many cases and proposed as an anthro-
pogenic marker of urban contamination because of its persis-
tence (about 100 days) in efﬂuent and surface waters (Clara
et al., 2004; Gagne et al., 2006). It is an antiepileptic drug
widely used to control seizures disorders, for relief of neural-
gia, and for a variety of mental disorders (Jones et al., 2002;
RxList, 2006). It has been frequently found in the aquatic
environment and detected in groundwater up to 610 ng l1
(Drewes et al., 2002). Antiepileptic drugs like CBZ act on
the CNS by decreasing the neuronal activity. Based on its tox-
icity level, CBZ classiﬁed as a potentially harmful drug to
aquatic organisms. Further, the impact of CBZ on aquatic
organisms particularly on freshwater ﬁsh and its ecotoxico-
logical data remain largely unknown (Ayscough et al., 2000;
Sanderson et al., 2004).
Fish respond to toxicants by altering their enzyme activities
and the inhibition or induction of these enzyme activities has
been used to indicate tissue damage (Nemcsok and Boross,
1982; Webb et al., 2005). Many enzymatic like carboxyl ester-
ase (CE), lactate dehydrogenase (LDH), alkaline and acid
phosphates (ALP, ACP), glutamate oxaloacetate transaminase
and glutamate pyruvate transaminase (GOT and GPT) are
measured as useful biomarkers to determine cellular impair-
ment and cell rupture. Transaminases such as GOT and
GPT play a vital role in protein and carbohydrate metabolism
and act as an indicator for tissue damage (Nemcsok et al.,1981; Nemcsok and Boross, 1982). LDH was also used as
indicative criteria of exposure due to chemical stress and
anaerobic capacity of tissue (Diamantino et al., 2001;
Rendon-von Osten et al., 2005).
The present investigation intended to monitor the impact
of a pharmaceutical drug, CBZ on a freshwater teleost ﬁsh
C. carpio using certain enzymatic parameters to assess the
possible risk caused by water borne drugs on survival and
physiology of aquatic organisms.2. Material and methods
The Department of Zoology, Bharathiar University, Coimba-
tore-641046 has been registered with the Committee for the
Purpose of Control and Supervision of Experiments on Ani-
mals (CPCSEA), Government of India and the experiment
was conducted as per the guidelines.
2.1. Test substance
Carbamazepine (CBZ) was chosen to evaluate its toxicity on
freshwater ﬁsh at acute and sub lethal level. Carbamazepine
(CAS No. 298-46-4, purity >99%) was purchased from
Sigma–Aldrich Corporation, USA. Carbamazepine (1.0 g)
was dissolved in appropriate amount of dimethylsulphoxide
(DMSO) and then diluted with double-deionized water to
make stock solutions. The DMSO concentration in the expo-
sure solutions, including controls, was 0.01% (v/v) which is
non-effective dose and used for further studies.
2.2. Fish and maintenance
C. carpio, a common freshwater ﬁsh (average length of 7.5 cm
and average weight of 15.0 g) and widely cultivable in many
aquaculture farms in India were obtained from Tamil Nadu
Fisheries Development Corporation Limited; Aliyar Fish
Farm, Tamil Nadu, India and they were safely transported
to the laboratory in well packed polythene bags containing
oxygenated water. Fish were stocked in a large tank containing
dechlorinated tap water and acclimatized to test conditions for
20 days to their use in the experiment. During acclimatization,
ﬁsh were fed with groundnut oil cake and rice bran in 2:1 ratio
at ad libitum. Water (three fourth of the water) was replaced
every 24 h to maintain healthy environment. The physico-
chemical characteristics of tap water such as temperature,
pH, dissolved oxygen, total alkalinity and total hardness were
measured according to APHA (1998) and maintained
(27.4 ± 1.2 C; 7.2 ± 0.09; 6.4 ± 0.04 mg ll; 18.6 ± 8.0 mg
ll; 18.4 ± 0.5 mg ll) during the study. A static bioassay
was performed on ﬁsh by the method of APHA (1971).
2.3. Preparation of 24 h LC50 and toxicity stress
The LC50 concentration of C. carpio for 24 h was calculated by
the probit analysis method of Finney (1978). Stock solution of
CBZ (1000 mg ll) was prepared using dechlorinated water
with nominal concentration (40, 50, 60, 70 and 80 mg ll) to lo-
cate LC50 value for 24 h. For each concentration, 10 ﬁsh were
randomly selected from the stock and introduced into separate
glass tanks (120 cm · 80 cm · 40 cm). For each concentration
a control was also maintained (free from toxicant) with three
Table 1 Changes in the enzymological parameters (GOT,
GPT and LDH) activity in a freshwater ﬁsh Cyprinus carpio
treated with acute concentration of carbamazepine (59.70 ppm;
24 h).
Enzymological
parameters
Control ﬁsh CBZ treated ﬁsh
GOT (IU/L)
Gill 57.00 ± 1.183 28.60 ± 0.400* (49.82)
Liver 64.40 ± 0.509 48.00 ± 2.154* (24.22)
Muscle 62.80 ± 0.200 25.20 ± 0.374* (59.87)
GPT (IU/L)
Gill 55.80 ± 0.490 42.20 ± 4.587* (24.37)
Liver 57.80 ± 0.490 62.20 ± 0.812* (+7.612)
Muscle 42.90 ± 0.872 58.30 ± 5.767* (+35.89)
LDH (IU/L)
Gill 4814.00 ± 9.311 4594.60 ± 55.12* (4.55)
Liver 1600.60 ± 5.306 4118.00 ± 7.092* (+157.27)
Muscle 2370.00 ± 9.121 4769.00 ± 6.811* (+101.22)
Values are means ± SE of ﬁve individual observations; () denotes
percent decrease and (+) denotes percent increase over control in
the parenthesis.
* Values are signiﬁcant at p< 0.05.
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occurred after 24 h was taken as the median lethal concentra-
tion (LC50), which was 59.70 mg l
l. 1/10th value of the LC50
concentration for 24 h of carbamazepine (5.97 mg ll) was ta-
ken for sublethal studies according to Sprague (1971).
2.4. Experimental design and exposure
2.4.1. Acute concentration of CBZ
A static acute toxicity test was employed, using 50 L aerated
glass tank (three replicates per treatment) ﬁlled with 30 l of
water. Then, LC50 (24 h) concentration of CBZ (59.70 mg l
l)
was added and 10 healthy ﬁshes from the stock were intro-
duced into each tank after removal of the same quantity of
water. A common control was also maintained simultaneously
(free from toxicant). After 24 h, ﬁsh from control and
experiment were taken randomly; tissues (gill, liver and mus-
cle) were removed for the estimation of GOT, GPT and
LDH activities.
2.4.2. Sublethal concentration of CBZ
For sublethal studies, 200 healthy ﬁsh from the stock were
randomly selected and transferred to aquaria of 500 l capac-
ity which was ﬁlled with tap water. After introduction of the
ﬁsh to the aquaria contains toxicant water, they were contin-
uously exposed to CBZ concentration (5.97 mg ll) under sta-
tic conditions for 35 days and the toxicant water was renewed
every day. A separate control was maintained (toxicant free).
During the study period ﬁsh were fed with ad libitum with
rice bran and groundnut oil cake (2:1 ratio), excess food
and faecal matter were removed from the aquaria to reduce
water quality deterioration. At the end of 7, 14, 21, 28 and
35 days exposure, samples of tissues (gill, liver and muscle)
from control and CBZ treated ﬁsh were collected and imme-
diately processed for enzymological (GOT, GPT and LDH)
studies.
2.5. Biomarker analysis
After removal of organs (gill, liver and muscle), blotted
dry with Whattman ﬁlter paper. Then 100 mg of each tissue
were homogenates (100 mg/2.5 mL, w/v) with 0.25 M sucrose
solution in ice cold condition (Hogeboom et al., 1948). The
homogenates were centrifuged for 20 min at 6000 rpm (ice
cold condition) and the clear supernatant ﬂuid was removed
and used to determine the level of GOT, GPT and LDH
activities. GOT and GPT activities were measured according
to Reitmen and Franckel (1957) at 505 nm against distilled
water. The LDH activity was measured following the
methodology described by Tietz (1976) at 340 nm against dis-
tilled water. Optical density was measured with the help of a
UV-spectrophotometer. Activity of all enzymes was expressed
in IU/L.
2.6. Statistical analysis
The statistical analysis was made between control and CBZ
treated groups and the mean value of ﬁve individual observa-
tions was taken for each parameter. The standard error for the
sample mean was calculated and the signiﬁcance of sample
means between control and drug treated ﬁsh was tested by
using student’s t-test.3. Results
3.1. Acute toxicity – enzymological changes
During acute treatment, GOT activity in gill, liver and muscle
of drug treated ﬁsh was found to be decreased (Table 1). A
maximum decrease was observed in liver (24.22%) followed
by gill (49.82%) and muscle (59.87%) of treated ﬁsh contrast
to control. GPT and LDH activities were observed to be signif-
icantly increased in liver and muscle of CBZ exposed ﬁsh,
while a signiﬁcant (p< 0.05) decrease in gill of treated ﬁsh
was noticed compared to control.
3.2. Sublethal toxicity
3.2.1. Changes in GOT activity
During sublethal treatment GOT activity in gill of drug treated
ﬁsh was slightly increased (0.69%) at the end of 7th day
(Fig. 1). After 7th day a progressive decrease in GOT activity
was observed up to 28th day. However at the end of 35th day
GOT activity was increased (24.08%) which is not signiﬁcant
(p> 0.05) when compared to that of the control values.
GOT activity was observed to be signiﬁcantly (p< 0.05) de-
creased throughout the study period in both liver and muscle
(Figs. 2 and 3).
3.2.2. Changes in GPT activity
The GPT level in gill, liver and muscle of the experimental
ﬁsh was found to be increased throughout the study
period (35 days) except at the end of 35th day in gill
(14.38%) and at the end of 7th day in liver (1.04%)
(Figs. 4–6). The values of gill during the study period were
not signiﬁcant (p> 0.05). The GPT activity was found to be
not signiﬁcant at the end of 7 and 35th day in liver and 35th
day in muscle.
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Figure 1 GOT activity in gill of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 2 GOT activity in liver of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 4 GPT activity in gill of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 3 GOT activity in muscle of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 5 GPT activity in liver of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 6 GPT activity in muscle of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 7 LDH activity in gill of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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The LDH activity in the gill of experimental ﬁsh was found to
be signiﬁcantly (p< 0.05) increased up to 14th day (1.968%).
After 14th day, a progressive decrease in LDH level was ob-
served throughout the study period (Fig. 7). An increase in
LDH activity was observed throughout the study period ex-
cept 35th day in liver (36.57%) and muscle (14.72%). The
values obtained during the study period in liver and muscle
were statistically signiﬁcant except the value of 35th day in
muscle (p< 0.05) (Figs. 8 and 9).
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Figure 8 LDH activity in liver of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Figure 9 LDH activity in muscle of control and carbamazepine
treated ﬁsh (5.97 ppm; 35 days). Bar represents SE of the mean.
Comparisons of means (control and treated ﬁsh) were done by
Student’s t-test. * Signiﬁcant at 5% level (p< 0.05).
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Ecotoxicity procedure for the mode of action of pharmaceuti-
cals on non-target organisms is presently attracted throughout
the world (Pomati et al., 2004). The presence of pharmaceuti-
cals in the aquatic environment may act on molecules, cells and
organs of organisms through unexpected mode of action (Fent
et al., 2006). Hoeger et al. (2008) suggested that although phar-
maceutical drugs are usually in low concentration, and are also
considered to be non-toxic compounds, they can exert toxic ef-
fects on non-target species. Knowledge on the acute toxicity of
pharmaceuticals could provide valuable information on the
mode of action and toxicity of these compounds. Recently,
many studies concentrated on the acute toxicity of pharmaceu-
ticals in organisms such as algae, cnidarians, crustaceans, mus-
sels and ﬁshes (Canesi et al., 2007; Yang et al., 2008; Haap
et al., 2008; Choi et al., 2008). However Laura Martı´n-Dı´az
et al. (2009) suggested that chronic studies based on speciﬁc
endpoints should be used in risk assessment. The present study
reports the acute and sublethal toxicity of carbamazepine on a
freshwater ﬁsh C. carpio using certain enzymatic parameters as
an end points test.
In the present study, the 24 h median lethal concentration
of CBZ to a freshwater teleost ﬁsh C. carpio was found to be
59.70 mg ll. For sublethal studies 1/10th of the above concen-
tration (5.97 mg ll) was used. Many studies have reported
that acute toxicity of CBZ to aquatic organisms was found
to be below 100 mg l1. The acute toxicity of CBZ was found
to be 17.2 mg l1 in Daphnia and 34.4 mg ll in midges,
43.0 lg ll in zebra ﬁsh (Thaker, 2005), 52.5 mg ll in Vibrioﬁscheri and 76.3 mg ll in Daphnia magna (Jos et al., 2003),
15.0–35.4 mg ll in medaka ﬁsh (Kim et al., 2007); 74.0–
138.0 mg ll to daphnids, zebra ﬁsh, and amphibian (Pﬂuger
and Dietrich, 2001). In the present study, CBZ was found to
be toxic to the ﬁsh C. carpio.
Aquatic vertebrates particularly ﬁsh appear to have similar
enzyme and receptor systems as in mammalian system (Hugg-
ett et al., 2003). Fish react to environmental toxicants by
changing and adapting their metabolic functions. Changes in
the enzymatic activities of aquatic organisms are widely used
to demonstrate tissue damage and also diagnosis of ﬁsh dis-
eases (Nemcsok and Boross, 1982; Pacheco and Santos,
2002). GOT and GPT usually present within cell membranes,
cytoplasm and mitochondria. The accumulation or binding
of toxicants in these cells may lead to damage and disintegra-
tion of cells, releasing these enzymes into blood circulation. As
a result, a dramatic increase in blood serum transaminases may
be expected during stress conditions (Nemcsok et al., 1981;
Galina et al., 1992). Elevation in GOT activity may indicate
muscle damage especially cardiac muscle, where as higher
GPT activity indicates damage in liver cells. Damage in liver,
kidney and gills is evident from elevated transaminase activi-
ties (Bernet et al., 2001). Changes in protein and carbohydrate
metabolism during stress conditions may also affect the activ-
ity of GOT and GPT and the elevation of transaminases can be
taken as a measure of compensatory mechanism to impaired
metabolism (Reddy and Venugopal, 1991). In aquatic moni-
toring, increased activities of GOT and GPT indicated hepatic
tissue damage. Increase in GOT and GPT activity in monocro-
tophos treated ﬁsh Channa punctatus indicates liver damage
(Agrahari et al., 2007). Increase in the activities of plasma
GOT and GPT can be used as a sensitive indicator to assess
even very minute cellular damage (Van der et al., 2003).
In the present study, the signiﬁcant increase in GOT and
GPT activity in gill, liver and muscle during acute and suble-
thal treatment indicates that the damage of the organs due
to drug toxicity or the organism tries to mitigate the drug in-
duced stress by increased rate of metabolism. However the ob-
served decrease in GOT and GPT activity in gill, liver and
muscle during acute and sublethal treatment signiﬁes that
detoxiﬁcation mechanism may not be sufﬁciently effective to
prevent the action of the drug on the system. The decreased
activities of GOT indicate disturbance in the structure and
integrity of cell organelles.
LDH involved in carbohydrate metabolism and the deter-
mination of this enzyme activity can be used as a good indica-
tor of the anaerobic capacity of a tissue, chemical exposure
and stress in ﬁsh (Gagnon, 2002; Rendon-von Osten et al.,
2005). LDH is present in all tissues and normally associated
with cellular metabolic action; it is used as potential marker
for assessing the toxicity of a chemical (Agrahari et al.,
2007). Any changes in protein and carbohydrate metabolism
may cause change in LDH activity (Abston and Yarbrough,
1976). Normal LDH activity patterns were found to be altered
in situations of chemical stress (Diamantino et al., 2001).
Elevated LDH activity in gills suggests that the aerobic catab-
olism of glycogen and glucose has shifted towards the forma-
tion of lactate, which may have adverse long-term effects on
the organisms (Szegletes et al., 1995). Increased release of
LDH into the medium may indicate damage in the integrity
of cell membranes or heart muscle (Nemcsok et al., 1984). In
the present study, the elevation of LDH activity in gill, liver
184 A. Malarvizhi et al.and muscle has occurred may be due to the metabolic changes
caused by the drug CBZ. Further disruption of respiratory epi-
thelium might have caused tissue hypoxia resulting in a de-
crease in oxidative metabolism which may be responsible for
increase in LDH activity in toxicant stressed animals (Gill
et al., 1990).
Jos et al. (2003) reported that leakage of LDH is a marker
of membrane permeability and cell death. They also suggested
that a slight increase in LDH activity may be due to stabiliza-
tion of cytoplasmic membrane and good viability of the
cultures exposed to CBZ. Elevation of LDH activity in mos-
quito ﬁsh, Gambusia holbrooki after acute exposure to cloﬁbric
acid may be due to stress response caused by cloﬁbric acid
(Nunes et al., 2004). Similarly in CBZ treated rainbow trout
Oncorhynchus mykiss, plasma enzymes like LDH and GPT lev-
els were increased during chronic exposure (Li et al., 2009).
The signiﬁcant increase of these enzymes may indicate the
changes in the histological structure of the hepatic and extra
hepatic tissues (Svoboda et al., 2001; El-Sayed et al., 2007).
In C. carpio, alterations in cellular responses such as increased
number of macrophages in liver and increase in the membrane
material in the cytoplasm were noticed after exposure to CBZ
(Triebskorn et al., 2007). Similarly, gill shows epithelial lifting,
hypertrophy and hyperplasia of mucus cells.
Inhibition in the activity of the LDH may be either due to
the change in mitochondrial membrane junction or it may be
due to impaired glycolysis (Sastry and Siddiqui, 1984). Yadav
et al. (2007) reported that fertilizer industry efﬂuent caused
marked reduction in tissue LDH activity in Channa striatus.
Decreased LDH activity may be due to lower metabolic rate
under toxic conditions (Agrahari et al., 2007). Gravel and
Vijayan (2007) reported that salicylate depressed liver GR
(glucocorticoid receptor) protein content and also modiﬁed
the stressor-mediated liver metabolic capacity in rainbow trout
O. mykiss. Severe histopathological alterations in gill and liver
and inhibition of cyclooxygenase activity were observed in dic-
lofenac treated ﬁsh Salmo trutta (Hoeger et al., 2005). Similar
histopathological alteration was also reported in rainbow trout
O. mykiss (Schwaiger et al., 2004) and cytological effects
(Triebskorn et al., 2004). Probably, the inhibition of LDH in
the present study during acute and sublethal treatment may
be due to impaired carbohydrate metabolism. Thus, the mea-
surement of alteration in the LDH activity in gill, liver and
kidney can be used as a biomarker indicating stress.
Li et al. (2010) reported a slight increase in SOD, CAT, and
GPx activity in CBZ-treated ﬁsh O. mykiss during the ﬁrst per-
iod (7 days). However, activities of antioxidant enzymes were
signiﬁcantly inhibited after 42 days. They also suggested that
prolonged exposure to CBZ resulted in excess reactive oxygen
species formation, ﬁnally resulting in oxidative damage to lip-
ids, proteins and inhibited antioxidant capacities in ﬁsh brain.
In rainbow trout O. mykiss after prolonged exposure to CBZ,
the levels of LPO and CP in ﬁsh gill were increased whereas
signiﬁcant inhibition of the antioxidant enzymes such as
SOD, CAT, GR, GPx, glutathione level and Na+, K+-ATP-
ase activity was noticed (Li et al., 2009). Inhibition of AchE
activity was noted in muscle and gills of black tiger shrimp
Penaeus monodon exposed to antibiotics (Tu et al., 2009).
In the present study it was concluded that CBZ induced alter-
ations in the activities of the enzymes such as GOT, GPT and
LDH in a freshwater ﬁsh C. carpio and these enzymes may be
used to assess the effects of carbamazepine in test organisms.5. Conclusion
The present study indicates that CBZ induced alterations in
the enzymatic activities of the freshwater ﬁsh both at acute
and sublethal concentrations. These alterations can be consid-
ered as a tool for biomonitoring of pharmaceutical drug sub-
stances in the aquatic environment. However, further studies
are needed to understand the risk of these compounds by using
different end points.
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